(CRBG) Corebridge Financial - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US21871X1090

Annuities, Life Insurance, Retirement Plans, Institutional Products

Diversified Financial Services
Market Cap in USD: 15,197m

IPO / Inception: 2022-09-15
Return 12m vs S&P 500: -11.9%

EPS (Earnings per Share)

EPS CAGR: -35.29%
EPS Trend: -52.5%

Last SUE: -1.31
Qual. Beats: 0

Revenue

Rev. CAGR: -45.28%
Rev. Trend: -21.9%

Last SUE: -0.68
Qual. Beats: 0

Dividends

Dividend Yield	3.09%
Yield on Cost 5y	5.85%
Yield CAGR 5y	27.79%
Payout Consistency	76.8%
Payout Ratio	44.7%

Risk via 5d forecast
Volatility	30.9%
Value at Risk 5%th	50.0%
Relative Tail Risk	-1.53%

Reward TTM
Sharpe Ratio	0.13
Alpha	-22.81
CAGR/Max DD	0.69

Character TTM
Hurst Exponent	0.470
Beta	1.388
Beta Downside	1.809

Drawdowns 3y
Max DD	32.88%
Mean DD	8.73%
Median DD	7.49%

Description: CRBG Corebridge Financial December 19, 2025

Corebridge Financial, Inc. (NYSE: CRBG) delivers retirement and insurance solutions across four business lines: Individual Retirement (fixed, indexed, and variable annuities), Group Retirement (in-plan recordkeeping, flexible annuities, and advisory services), Life Insurance (term, whole, index universal, and guaranteed universal life), and Institutional Markets (stable-value wraps, pension-risk-transfer annuities, private-placement life and annuity products, and guaranteed investment contracts). The firm, originally SAFG Retirement Services, was founded in 1998 and is headquartered in Houston, Texas.

Key recent metrics: Q3 2024 reported a 7% YoY increase in annuity premium volume, driven by rising interest-rate spreads that make fixed-index products more attractive; the Life Insurance segment posted a combined ratio of 92.3%, indicating underwriting profitability despite a competitive market. Macro-level drivers include the aging U.S. population-projected to push the 65-plus cohort to 22% of the population by 2030-and the Fed’s policy cycle, which influences the pricing of fixed-income-linked annuities and stable-value wraps.

For a deeper dive into CRBG’s valuation nuances, consider exploring ValueRay’s analytical tools.

Piotroski VR‑10 (Strict, 0-10) 3.5

Net Income (991.0m TTM) > 0 and > 6% of Revenue (6% = 172.5m TTM)

FCFTA 0.00 (>2.0%) and ΔFCFTA -0.16pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 1939 % (prev 2579 %; Δ -640.7pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.00 (>3.0%) and CFO 1.62b > Net Income 991.0m (YES >=105%, WARN >=100%)

Net Debt (10.70b) to EBITDA (2.42b) ratio: 4.42 <= 3.0 (WARN <= 3.5)

Current Ratio 6.96 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (540.6m) change vs 12m ago -7.92% (target <= -2.0% for YES)

Gross Margin 80.35% (prev 78.73%; Δ 1.62pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 0.71% (prev 0.64%; Δ 0.06pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 3.50 (EBITDA TTM 2.42b / Interest Expense TTM 565.0m) >= 6 (WARN >= 3)

Altman Z'' 1.08

(A) 0.14 = (Total Current Assets 65.09b - Total Current Liabilities 9.36b) / Total Assets 411.29b

(B) 0.04 = Retained Earnings (Balance) 17.68b / Total Assets 411.29b

(D) 0.02 = Book Value of Equity 8.66b / Total Liabilities 396.97b

Total Rating: 1.08 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 49.54

1. Piotroski 3.50pt

2. FCF Yield -4.23%

3. FCF Margin 56.31%

4. Debt/Equity 0.81

5. Debt/Ebitda 4.42

6. ROIC - WACC (= -0.35)%

7. RoE 8.04%

8. Rev. Trend -21.89%

9. EPS Trend -52.50%

What is the price of CRBG shares?

As of January 11, 2026, the stock is trading at USD 31.08 with a total of 3,360,906 shares traded.
Over the past week, the price has changed by +2.34%, over one month by +2.04%, over three months by -2.69% and over the past year by +6.55%.

Is CRBG a buy, sell or hold?

Corebridge Financial has received a consensus analysts rating of 4.07. Therefore, it is recommended to buy CRBG.

Strong Buy: 6
Buy: 5
Hold: 2
Sell: 0
Strong Sell: 1

What are the forecasts/targets for the CRBG price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	38.7	24.5%
Analysts Target Price	38.7	24.5%
ValueRay Target Price	35.7	14.7%

CRBG Fundamental Data Overview January 09, 2026

P/E Trailing = 20.4966
P/E Forward = 5.9347
P/S = 0.8289
P/B = 1.1557
Beta = 0.938
Revenue TTM = 2.88b USD
EBIT TTM = 1.98b USD
EBITDA TTM = 2.42b USD
Long Term Debt = 11.02b USD (from longTermDebt, last quarter)
Short Term Debt = 9.36b USD (from shortTermDebt, last quarter)
Debt = 11.02b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.70b USD (from netDebt column, last quarter)
Enterprise Value = -38.26b USD (15.20b + Debt 11.02b - CCE 64.47b)
Interest Coverage Ratio = 3.50 (Ebit TTM 1.98b / Interest Expense TTM 565.0m)
EV/FCF = -23.63x (Enterprise Value -38.26b / FCF TTM 1.62b)
FCF Yield = -4.23% (FCF TTM 1.62b / Enterprise Value -38.26b)
FCF Margin = 56.31% (FCF TTM 1.62b / Revenue TTM 2.88b)
Net Margin = 34.47% (Net Income TTM 991.0m / Revenue TTM 2.88b)
Gross Margin = 80.35% ((Revenue TTM 2.88b - Cost of Revenue TTM 565.0m) / Revenue TTM)
Gross Margin QoQ = 81.35% (prev 81.41%)
Tobins Q-Ratio = -0.09 (set to none) (Enterprise Value -38.26b / Total Assets 411.29b)
Interest Expense / Debt = 1.23% (Interest Expense 135.0m / Debt 11.02b)
Taxrate = 21.41% (600.0m / 2.80b)
NOPAT = 1.55b (EBIT 1.98b * (1 - 21.41%))
Current Ratio = 6.96 (Total Current Assets 65.09b / Total Current Liabilities 9.36b)
Debt / Equity = 0.81 (Debt 11.02b / totalStockholderEquity, last quarter 13.54b)
Debt / EBITDA = 4.42 (Net Debt 10.70b / EBITDA 2.42b)
Debt / FCF = 6.61 (Net Debt 10.70b / FCF TTM 1.62b)
Total Stockholder Equity = 12.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.24% (Net Income 991.0m / Total Assets 411.29b)
RoE = 8.04% (Net Income TTM 991.0m / Total Stockholder Equity 12.32b)
RoCE = 8.48% (EBIT 1.98b / Capital Employed (Equity 12.32b + L.T.Debt 11.02b))
RoIC = 6.45% (NOPAT 1.55b / Invested Capital 24.09b)
WACC = 6.80% (E(15.20b)/V(26.21b) * Re(11.03%) + D(11.02b)/V(26.21b) * Rd(1.23%) * (1-Tc(0.21)))
Discount Rate = 11.03% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -7.59%
[DCF Debug] Terminal Value 83.66% ; FCFF base≈1.85b ; Y1≈2.02b ; Y5≈2.53b
Fair Price DCF = 92.60 (EV 57.40b - Net Debt 10.70b = Equity 46.70b / Shares 504.4m; r=6.80% [WACC]; 5y FCF grow 10.00% → 2.90% )
EPS Correlation: -52.50 | EPS CAGR: -35.29% | SUE: -1.31 | # QB: 0
Revenue Correlation: -21.89 | Revenue CAGR: -45.28% | SUE: -0.68 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.21 | Chg30d=-0.004 | Revisions Net=+0 | Analysts=11
EPS next Year (2026-12-31): EPS=5.29 | Chg30d=-0.098 | Revisions Net=-3 | Growth EPS=+21.2% | Growth Revenue=+8.0%

Additional Sources for CRBG Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle